Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-14 | Kymera Therapeutics, Inc. | Booth Bruce
(Director) |
S | Common Stock | D | 127543 | $39.31 - $41.51 | $5,133,258 |
| 2024-03-11 | Kymera Therapeutics, Inc. | Atlas Venture Ass...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 353357 | $41.94 - $43.42 | $14,912,371 |
| 2024-03-11 | Kymera Therapeutics, Inc. | Booth Bruce
(Director) |
S | Common Stock | D | 353357 | $41.94 - $43.42 | $14,912,371 |
| 2024-03-04 | Kymera Therapeutics, Inc. | Gollob Jared
(Chief Medical Officer) |
S | Common Stock | D | 3344 | $41.41 - $43.26 | $139,966 |
| 2024-03-01 | Kymera Therapeutics, Inc. | Gollob Jared
(Chief Medical Officer) |
A | Common Stock | A | 24375 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Kymera Therapeutics, Inc. | Chadwick Jeremy G
(Chief Operating Officer) |
A | Common Stock | A | 13425 | $0.00 - $0.00 | $0 |
| 2024-02-20 | Kymera Therapeutics, Inc. | Albers Jeffrey W.
(Director) |
S | Common Stock | D | 5000 | $39.05 - $39.07 | $195,256 |
| 2024-02-20 | Kymera Therapeutics, Inc. | Albers Jeffrey W.
(Director) |
M | Common Stock | A | 5000 | $10.34 - $10.34 | $51,699 |
| 2024-02-09 | Kymera Therapeutics, Inc. | Gollob Jared
(Chief Medical Officer) |
S | Common Stock | D | 46137 | $35.39 - $36.09 | $1,638,071 |
| 2024-02-09 | Kymera Therapeutics, Inc. | Gollob Jared
(Chief Medical Officer) |
M | Common Stock | A | 46137 | $2.08 - $2.08 | $95,964 |
| 2024-01-23 | Kymera Therapeutics, Inc. | Albers Jeffrey W.
(Director) |
S | Common Stock | D | 10000 | $30.05 - $30.05 | $300,470 |
| 2024-01-23 | Kymera Therapeutics, Inc. | Albers Jeffrey W.
(Director) |
M | Common Stock | A | 10000 | $10.34 - $10.34 | $103,400 |
| 2024-01-02 | Kymera Therapeutics, Inc. | Mainolfi Nello
(Chief Executive Officer) |
M | Common Stock | A | 9000 | $2.08 - $2.08 | $18,720 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |